انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
$4.4 M Diabetes Patch Brand: Hidden Gem or Hidden Trap?
Manage episode 518165968 series 2842765
In this episode of Acquisitions Anonymous, the hosts dig into a $4.4 M e‑commerce business in the diabetes sensor accessory space and debate whether its 41% net margin, Australian base, and licensing opportunity make it a smart buy—or a risky startup in disguise.
Business Listing – https://websiteproperties.com/websites/13755-sticking-with-success-great-business-opportunity-in-the-growing-diabetes-market/
Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.
💰 Sponsored by:
Go High Level – The all-in-one sales and marketing platform built for agencies and entrepreneurs. Automate, manage, and grow your business at https://www.gohighlevel.com
Capital Pad – A platform connecting accredited investors with vetted small business acquisition deals. Discover exclusive opportunities at https://capitalpad.com
The team explores a listing for a home‑based Australian business selling branded adhesive patches for continuous glucose monitors (CGMs) — the listing claims approximately US $3.5 M in trailing 12‑month revenue (converted from AUD) and US $1.46 M in cash‑flow (~41 % net margin). The business model includes Amazon FBA plus a couple of major U.S. pharmacy accounts, with the owner working ~10 hours/week.
Key Highlights:
- Asking price ~US $4.4 M, trailing cash‑flow US $1.46 M (≈41 % net margin)
- Business based in Australia, selling (via Amazon + pharmacies) consumable patches for CGMs — a growing diabetes adjacent market
- Opportunity for U.S. expansion + licensing of characters/brands to build a moat
- Risks: Australian entity, potential Amazon seller‑migration issues, unclear SBA financing, low barrier to entry in consumables
- Strategic path: Use Aussie cash‑flow to buy and build U.S. subsidiary, invest heavily in influencer / TikTok, build brand/licensing to protect margin
Subscribe to weekly our Newsletter and get curated deals in your inbox
Advertise with us by clicking here
- Do you love Acquanon and want to see our smiling faces? Subscribe to our Youtube channel.
- Do you enjoy our content? Rate our show!
- Follow us on Twitter @acquanon Learnings about small business acquisitions and operations.
For inquiries or suggestions, email us at [email protected]
447 حلقات
$4.4 M Diabetes Patch Brand: Hidden Gem or Hidden Trap?
Acquisitions Anonymous - #1 for business buying, selling and operating
Manage episode 518165968 series 2842765
In this episode of Acquisitions Anonymous, the hosts dig into a $4.4 M e‑commerce business in the diabetes sensor accessory space and debate whether its 41% net margin, Australian base, and licensing opportunity make it a smart buy—or a risky startup in disguise.
Business Listing – https://websiteproperties.com/websites/13755-sticking-with-success-great-business-opportunity-in-the-growing-diabetes-market/
Welcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.
💰 Sponsored by:
Go High Level – The all-in-one sales and marketing platform built for agencies and entrepreneurs. Automate, manage, and grow your business at https://www.gohighlevel.com
Capital Pad – A platform connecting accredited investors with vetted small business acquisition deals. Discover exclusive opportunities at https://capitalpad.com
The team explores a listing for a home‑based Australian business selling branded adhesive patches for continuous glucose monitors (CGMs) — the listing claims approximately US $3.5 M in trailing 12‑month revenue (converted from AUD) and US $1.46 M in cash‑flow (~41 % net margin). The business model includes Amazon FBA plus a couple of major U.S. pharmacy accounts, with the owner working ~10 hours/week.
Key Highlights:
- Asking price ~US $4.4 M, trailing cash‑flow US $1.46 M (≈41 % net margin)
- Business based in Australia, selling (via Amazon + pharmacies) consumable patches for CGMs — a growing diabetes adjacent market
- Opportunity for U.S. expansion + licensing of characters/brands to build a moat
- Risks: Australian entity, potential Amazon seller‑migration issues, unclear SBA financing, low barrier to entry in consumables
- Strategic path: Use Aussie cash‑flow to buy and build U.S. subsidiary, invest heavily in influencer / TikTok, build brand/licensing to protect margin
Subscribe to weekly our Newsletter and get curated deals in your inbox
Advertise with us by clicking here
- Do you love Acquanon and want to see our smiling faces? Subscribe to our Youtube channel.
- Do you enjoy our content? Rate our show!
- Follow us on Twitter @acquanon Learnings about small business acquisitions and operations.
For inquiries or suggestions, email us at [email protected]
447 حلقات
كل الحلقات
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.